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ABSTRACT
This study investigated the lipid profile (LP) of type-2 diabetics and non-diabetic patients presenting at Irrua 
Specialist Teaching Hospital, Irrua, Edo State, Nigeria, with a view to assessing the risk of cardiovascular disease 
among the diabetics. Twenty (20) diabetic and 20 non-diabetic patients (control) formed the study population. Total 
cholesterol (TC), triacylglycerol (TG), high density lipoprotein-cholesterol (HDL-C), and low density lipoprotein-
cholesterol (LDL-C) were assayed for each group using standard biochemical methods, while the fasting blood 
glucose levels of the patients were assayed using the glucose oxidase method. The results showed higher mean TC 
and HDL-C levels among the diabetic patients than their non-diabetic counterparts and the observed differences
were statistically significant (p<0.05). The mean glucose, TG, and LDL-C were equally higher among the diabetics 
than their non-diabetic counterparts, but in this instance, the differences were not statistically significant (P>0.05). 
Regardless of the high lipid profile levels among the diabetics, the values obtained fell within acceptable range; 
suggesting that the patients were responding to treatment or life style changes.
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INTRODUCTION 
Total lipid profile or lipid panel of an individual is a 
contributory factor resulting from blood cholesterol 
along with its associated varieties of lipoproteins i.e. 
high-density lipoproteins (HDL-C or α-lipoproteins), 
very low density lipoproteins (VLDL-C or pre-β-
lipoproteins) and triglycerides (Dasofunjo et al., 
2013). Dyslipidaemia is one of the major 
cardiovascular disease (CVD) risk factors and plays 
an important role in the progress of atherosclerosis, 
the underlying pathology of CVD (Singh and Kumar, 
2012). According to the American Diabetes 
Association in 1998, these are more complex 
abnormalities that are caused by the interrelation 
among obesity, insulin resistance and 
hyperinsulinism (American Diabetes Association, 
1998). 
It noteworthy to emphasize that fatty tissue is 
exclusively related to risk factors, such as the altered 
insulin and lipid profile which can contribute to the 
development of the insulin resistance syndrome
comprising several risk factors for the emergency of 
cardiovascular complications (Singh and Kumar, 
2012). In patients with type 2 diabetes, it is most 
commonly characterized by elevated TG and reduced 
HDL-C. 
Diabetic patients with type 2 diabetes mellitus are at 
greater risk of developing vascular diseases because 
of lipid changes (Shaikh et al., 2010). Type 2 
diabetes is associated with a cluster of interrelated 
plasma lipid and lipoprotein abnormalities, including 
reduced HDL cholesterol, a predominance of small 
dense LDL particles and elevated triglycerides 
(American Diabetes Association, 2003). These 
abnormalities occur in many patients despite normal 
LDL cholesterol levels. These changes are also a 
feature of the insulin resistance syndrome (also 
known as the metabolic syndrome), which underlies 
many cases of type 2 diabetes (Krauss, 2004). Insulin 
resistance has striking effects on lipoprotein size and 
subclass particle concentration for VLDL, LDL, and 
HDL (Reaven et al., 1993; Garvey et al., 2003).
In diabetics, lipid abnormalities and insulin are 
critically discussed. Lipid abnormalities in diabetics 
are described as increased serum triglycerides, very 
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low density lipoproteins, low density lipoproteins and 
lowering of high density lipoproteins in patients with 
type 2 diabetes mellitus (American Diabetes 
Association, 2003). Shaikh et al. (2010) observed 
that persons with Type 2 diabetes were suffering 
from preventable vascular complications at Karachi. 
It was studied that more food with less exercise 
predisposes to features of metabolic syndrome. 
However, lifestyle modifications were proposed to be 
required for healthy life. 
Type 2 diabetes mellitus is the predominant form of 
diabetes mellitus worldwide; thus, this study was 
conceived to investigate the lipid profile of Type 2 
diabetic patients presenting for treatments at Irrua 
Specialist Hospital (ISTH), Irrua, Edo State, Nigeria.
MATERIALS AND METHODS
Study Design: The subjects used in the study were 
diabetic patients presenting at Irrua Specialist 
Teaching Hospital, Irrua, Edo State, Nigeria. A total 
of 20 diabetic patients (13 males, 7 females) and 20 
healthy controls (15 males, 5 females) were randomly 
selected. The mean age for the total (combined males 
and females) was 58 (ranged 52 – 81) years and the 
mean age values for males and females were 62 
(ranged 51-73) and 53 (ranged 35-65) years 
respectively. Patients with other ailments and 
metabolic disorders were excluded from the study. 
Diabetes was ruled out in the control group by asking 
questions about the clinical signs of diabetes such as 
polyuria, polydipsia and recent weight loss. 
Laboratory tests were also used to confirm the 
absence of diabetes in the control group. Ethical 
clearance was sought and obtained for the study from 
the hospital. The aim of the study was explained to 
the subjects by the physicians and those who gave 
informed consent were included in the study by the 
researchers.
Sample Collection: In both subjects, venous blood 
samples were obtained after overnight fast into tubes 
containing lithium heparin (for lipid profile) and 
EDTA (for blood glucose) as anticoagulants. The 
samples were centrifuged at 1500 rpm for 5 minutes 
to obtain the plasma. 
Laboratory Analysis: Plasma cholesterol, 
triacylglycerol, high density lipoprotein – cholesterol 
(HDL-C), and glucose were determined using kit 
based on enzymatic method from Randox laboratory, 
Aldren, USA as described by Tietz (1990). Fasting 
blood glucose concentration was determined using kit 
based on glucose oxidase method of Barham and 
Trinder (1972). LDL-C was calculated indirectly by 
the method of Friedwald et al. (1972) as shown 
below: 
LDL-C = Total cholesterol – HDL-C + TG/5
The lipid profile of the subjects was classified based 
on the ATP III model (NCEP, 2001).
Statistics: The data obtained in this study were 
subjected to student t-test analysis using GraphPad 
InStat tm (V2.04a). Results were recorded as mean ± 
standard error of mean. The difference was 
considered statistically significant when P<0.05.
RESULTS
The result of the lipid profile of diabetics and non-
diabetics are shown in Table 1. The results represents
mean value of triplicate determinations ± standard 
error of mean. The various biochemical parameters 
include high density lipoprotein-cholesterol (HDL-
C), low density lipoprotein (LDL-C), triglycerides, 
total cholesterol and glucose concentration. 
The results showed that the diabetic group had a 
significantly higher mean fasting glucose level 
(P>0.05), confirming their hyperglycaemic state. 
LDL-C and triglyceride were non-significantly higher 
in diabetics than in the control group while HDL-C 
and total cholesterol was significantly higher in the 
diabetic than in the control group. However, diabetics 
recorded a higher HDL-C, LDL-C, triglyceride and 
total cholesterol than the control groups (Figure 1).
DISCUSSION
From the result, patients with diabetes recorded a 
non-significantly (P>0.05) elevated levels of LDL-C 
(104.55 ± 9.86mg/dl) and triacylglycerol (90.05 ± 
8.95mg/dl); and a significantly (P<0.05) higher levels 
of HDL-C (77.95 ± 6.78mg/dl) and total cholesterol 
(153.93mg/dl) compared to the control group (non-
diabetic patients).
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Table 1: Biochemical Parameters of Diabetics and Control
Parameters (mg/dl) Diabetics Control P-Value
HDL-C 77.95 ± 6.78 45.40 ± 5.62 0.0007*
LDL-C 104.55 ± 9.86 99.15 ± 8.29 0.6774
Triglyceride 90.05 ± 8.95 68.40 ± 10.52 0.1252
Total Cholesterol 191.65 ± 8.35 153.8.93 0.0035*
Glucose 197.58 ± 85.75 85.76 ± 11.14 0.130
HDL-C = high density lipoprotein-cholesterol, LDL-C = low density lipoprotein cholesterol, * = P<0.05 (non-
significant).
Figure 1: Lipid Panel of Diabetics and Non-diabetics
There have been contradicting reports on the lipid 
profile of diabetics. Some workers found high levels 
of lipids in diabetic patients (Idogun et al., 2007), 
others reported normal (Agaba et al., 2005) or even 
lower levels compared to controls. Oluyomi et al. 
(2010) reported a non-significant increase in plasma 
LDL-C and TC in diabetic patients when compared 
with normal non-diabetic controls. This agrees with 
the significant increase in LDL-C of diabetic patients 
compared to non-diabetic patients observed in this 
study. The observation may be due to the level of 
management of diabetes in some patients being 
studied, as adequate monitoring leading to necessary 
lifestyle adjustments have been found to be very 
effective in maintaining normal lipid levels and thus 
lowering the risk of coronary heart diseases in 
diabetic patients (Ugwu et al., 2009). 
According to NCEP (2001), LDL levels <100 is 
considered to be optimal, 100–129mg/dl is 
considered to be near optimal, 130–159mg/dl is 
considered to be on the borderline, 160–189mg/dl is 
seen to be high, while ≥190mg/d above is considered 
to be very high. Also, triglyacylglycerol levels 
<150mg/dl was reported to be normal, 150–159mg/dl 
is considered to be on the borderline while 200–
499mg/dl was considered to be associated with some 
cardiovascular diseases. These however suggested 
that irrespective of the non-significantly (P>0.05) 
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diabetic patients, the values still fell within the safe 
range of LDL-C and triglyceride. LDL-C is 
considered as “bad cholesterol” because they can 
transport their content of fat molecules into artery 
walls, attract macrophages, and thus 
drive atherosclerosis (Superko et al., 2002). 
Triglycerides as a major component of very low-
density lipoprotein (VLDL) and chlylomicrons play 
an important role in metabolism of energy sources 
and transporter of dietary fat. High levels of 
triglycerides in the bloodstream have been linked to 
atherosclerosis and by extension, the risk of heart 
disease and stroke.
Khoo et al. (1997) reported that the higher the HDL-
C, the lower the risk of developing atherosclerosis. 
HDL is known to be “good cholesterol” because they 
can remove fat molecules from macrophages in the 
wall of the arteries. The study revealed a significantly 
(P<0.05) higher HDL-C in diabetic patients 
compared to the control which thus, suggests a lower 
risk of developing cardiovascular diseases. Also, the 
TC levels were desirable (<200mg/dl) in both 
diabetic patients and control as reported by NCEP 
(2001). According to Lecerf and Lorgeril (2011), 
cholesterol is required to build and maintain body 
membranes; it modulates membrane fluidity over the 
range of physiological temperatures. Through the 
interactions with the phospholipids fatty acid chains, 
cholesterol increases membrane packing thus, 
reducing membrane fluidity. However, increased 
levels of cholesterol have been reported to be 
associated with several ailments such as 
cardiovascular diseases, and atherosclerotic 
disorders.
CONCLUSION
The findings of this study have shown that diabetic 
patients had a controlled lipid profile due to treatment 
and medical advice from the medical practitioner. 
That the diabetic patients recorded an appreciable 
range of lipid profile suggests the need for proper 
management of diabetes mellitus in terms of adequate 
medications and life style changes.
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